Kiyotaka Nakamagoe

10PUBLICATIONS
16CO-AUTHORS
Neurology and neuromuscular diseasesOptical technologyToxicology (incl. clinical toxicology)Fish pests and diseasesPhotochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 03, 2023
Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system.

Hideaki Ishido, Shigeru Chiba, Hana Takahashi

|May 03, 2023
Glutamine/arginine site-unedited GluA2 mRNA in cerebrospinal fluid as a biomarker for amyotrophic lateral sclerosis.

Takashi Hosaka, Hiroshi Tsuji, Makoto Terada

|Mar 18, 2023
Cases of aquaporin-4-positive neuromyelitis optica spectrum disorder with successful tapering of prednisolone to less than 3 mg/day after satralizumab administration.

Kiyotaka Nakamagoe, Mayuko Tanaka, Kota Igari

|Mar 05, 2023
Saccadic oscillations as a biomarker of clinical symptoms in amyotrophic lateral sclerosis.

Kiyotaka Nakamagoe, Shunya Matsumoto, Nozomi Touno

|Aug 16, 2021
Correction to: Remarkable clinical responses of non-fluctuating Parkinson's disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ~ 300 mg/day to opicapone 25 mg/day.

Kiyotaka Nakamagoe, Hiroshi Tsuji, Kazuhiro Ishii

|Aug 04, 2021
Remarkable clinical responses of non-fluctuating Parkinson's disease (PD) after alternating catechol O-methyltransferase inhibitors: case series switching from entacapone 200 ~ 300 mg/day to opicapone 25 mg/day.

Kiyotaka Nakamagoe, Hiroshi Tsuji, Kazuhiro Ishii

Pageof 2